Clinical trial

Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment

Name

PI20-1770 A.4.2

Description

The main objective of the study is to assess whether the performance of type 2 quadratus lumborum block produces an improvement in the quality of life of the patient with osteoarthritis of the hip.

Trial arms

Trial start

2020-09-01

Estimated PCD

2022-09-01

Trial end

2025-12-01

Status

Recruiting

Treatment

levobupivacaine

local anesthetic

Arms:

quadratus lumborum

Other names:

chirocane

ultrasound device

scream

Arms:

quadratus lumborum

Size

100

Primary endpoint

relieve chronic hip pain

2 months

Eligibility criteria

Inclusion Criteria: * Sign informed consent (Annex 2) * Age 18-85 years * Cartilage injury (coxarthrosis) hip * Illness \<1 year of evolution * Patients with pain after treatment with physical therapy, exercises, NSAIDs. * EVN\> 5 Exclusion Criteria: * Refusal of the patient * Allergy to the drugs used * Contraindication for performing the technique * Intraarticular treatment in the previous 3 months * Pregnancy

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'CASE_CONTROL', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}

Updated at

2024-03-05

1 organization

1 product

3 indications

Organization

Hospital Medina del Campo

Product

Indication

Indication

Indication